Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Bob Geng

Title(s)Associate Clinical Professor (Voluntary), Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies. Dermatol Ther (Heidelb). 2026 Feb 12. Blauvelt A, Kircik L, Simpson EL, Lio P, Eichenfield LF, Prajapati VH, Grewal P, Lynde C, Hong HC, Sturm D, Kallender H, Ren H, Paranagama D, Wong GKW, Geng B. PMID: 41678112.
      View in: PubMed   Mentions:
    2. Impact of type 2-targeted therapies on respiratory infection risk. Curr Opin Allergy Clin Immunol. 2026 Feb 01; 26(1):15-20. Smiley K, Zuhdi N, Geng B. PMID: 41355433.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. Dual dysregulation of TNF/interferon signaling and classical monocytes are implicated in Reactive Infectious Mucocutaneous Eruptions. JCI Insight. 2025 Nov 20. Tan Z, Wu G, Salgado Figueroa D, Dutta P, Jaeger Z, Mazurie M, Schairer D, Eichenfield D, Tom WL, Galli L, Eichenfield L, Geng B, Hinds B, Hoffman HM, Broderick L, Croker B, Ay F, Oldenburg R. PMID: 41264360.
      View in: PubMed   Mentions:    Fields:    
    4. Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis? Dermatol Ther (Heidelb). 2025 Nov; 15(11):3391-3407. Simpson EL, Silverberg JI, Geng B, Carrascosa JM, Bieber T, Brunner PM, Staumont-Sallé D, Ji C, Biswas P, Feeney C, Hernández-Martín I, Rebollo Laserna FJ, Koppensteiner H. PMID: 40987931; PMCID: PMC12550080.
      View in: PubMed   Mentions:
    5. Comparative single-cell lineage bias in human and murine hematopoietic stem cells. Haematologica. 2026 Feb 01; 111(2):632-645. Shamie I, Bliss-Moreau M, Lee JC, Mathieu R, Hoffman HM, Geng B, Lewis NE, Zhu YP, Croker BA. PMID: 40671503; PMCID: PMC12862340.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    6. Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities. Ann Allergy Asthma Immunol. 2025 Oct; 135(4):425-433.e4. Paller AS, Soong W, Boguniewicz M, Geng B, Thyssen JP, Bennike N, Schneider S, Wollenberg A. PMID: 40555305.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy. J Clin Immunol. 2025 Mar 27; 45(1):84. Dorsey MJ, Butte MJ, Lieberman JA, Lehman H, Fausnight T, Keller MD, Fradette C, Hershfield MS, Pozos TC, Rozova A, Wall LA, Bednarski JJ, Tarrant TK, Chong HJ, Geng B, Temin NT, Laubach SS, Lin L, Mousallem T, Walter JE. PMID: 40140214; PMCID: PMC11947034.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    8. Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age. J Allergy Clin Immunol Pract. 2025 May; 13(5):1164-1175.e2. Cork MJ, Deleuran M, Geng B, Silverberg JI, Simpson EL, Stein Gold LF, Irvine AD, Romero W, Valdez H, Fan H, Alderfer J. PMID: 40081761.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis. Br J Dermatol. 2024 09 18; 191(4):488-496. Guttman-Yassky E, Croft M, Geng B, Rynkiewicz N, Lucchesi D, Peakman M, van Krinks C, Valdecantos W, Xing H, Weidinger S. PMID: 38836560.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. Corrigendum: Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency. Front Immunol. 2024; 15:1430313. Geng B, Clark K, Evangelista M, Wolford E. PMID: 38873596; PMCID: PMC11175654.
      View in: PubMed   Mentions:    Fields:    
    11. Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study. J Dermatolog Treat. 2024 Dec; 35(1):2344589. Magnolo N, Cameron MC, Shahriari M, Geng B, Calimlim BM, Teixeira H, Hu X, Yang Y, Liu Y, Zhang S, Sancho Sanchez C, Altman K, Langley RG. PMID: 38697950.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    12. Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patients. Pediatr Dermatol. 2024 Mar-Apr; 41(2):210-214. Tracy A, Loop L, Bhatti S, Anterasian C, Kellogg C, Smiley K, Wu A, Geng B, Eichenfield L. PMID: 38234080.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Implementation of a pediatric synchronous multidisciplinary severe asthma clinic and real-world outcomes. Ann Allergy Asthma Immunol. 2024 03; 132(3):392-393. Patel D, Revier MD, Tambay A, Geng B. PMID: 37898325.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency. Front Immunol. 2022; 13:1075527. Geng B, Clark K, Evangelista M, Wolford E. PMID: 36818468; PMCID: PMC9932595.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    15. Rapid genome sequencing identifies novel variants in complement factor I. Cold Spring Harb Mol Case Stud. 2022 12; 8(7). Rodriguez KM, Vaught J, Dilley M, Ellsworth K, Heinen A, Abud EM, Zhang Y, Smith RJH, Sheets R, Geng B, Hoffman HM, Worthen HM, Dimmock D, Coufal NG. PMID: 36577522; PMCID: PMC9808552.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies. Front Immunol. 2022; 13:1110388. Kobayashi RH, Gupta S, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Turpel-Kantor E, Litzman J. PMID: 36605207; PMCID: PMC9809273.
      View in: PubMed   Mentions: 1     Fields:    
    17. Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies. Clin Exp Immunol. 2022 12 15; 210(2):91-103. Kobayashi RH, Litzman J, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Höller S, Turpel-Kantor E, Kreuwel H, Speer JC, Gupta S. PMID: 36208448; PMCID: PMC9750824.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Allergen Content and Protease Activity in Milk Feeds from Mothers of Preterm Infants. Breastfeed Med. 2022 Nov; 17(11):947-957. Luskin K, Mortazavi D, Bai-Tong S, Bertrand K, Chambers C, Schulkers-Escalante K, Ahmad A, Luedtke S, O'Donoghue AJ, Ghassemian M, Geng B, Leibel SL, Leibel SA. PMID: 36251466; PMCID: PMC10081709.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    19. A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib. JAAD Case Rep. 2022 Dec; 30:21-23. Tracy A, Kahn J, Geng B, Russo M, Safai B. PMID: 36345411; PMCID: PMC9636012.
      View in: PubMed   Mentions: 1  
    20. Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma. Allergy Asthma Proc. 2022 09 01; 43(5):446-453. Wangberg H, Mortazavi D, Kitsen J, Sanni A, Leibel S, Geng B. PMID: 36065107.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients. J Clin Immunol. 2022 11; 42(8):1748-1765. Geier CB, Ellison M, Cruz R, Pawar S, Leiss-Piller A, Zmajkovicova K, McNulty SM, Yilmaz M, Evans MO, Gordon S, Ujhazi B, Wiest I, Abolhassani H, Aghamohammadi A, Barmettler S, Bhar S, Bondarenko A, Bolyard AA, Buchbinder D, Cada M, Cavieres M, Connelly JA, Dale DC, Deordieva E, Dorsey MJ, Drysdale SB, Ehl S, Elfeky R, Fioredda F, Firkin F, Förster-Waldl E, Geng B, Goda V, Gonzalez-Granado L, Grunebaum E, Grzesk E, Henrickson SE, Hilfanova A, Hiwatari M, Imai C, Ip W, Jyonouchi S, Kanegane H, Kawahara Y, Khojah AM, Kim VH, Kojic M, Koltan S, Krivan G, Langguth D, Lau YL, Leung D, Miano M, Mersyanova I, Mousallem T, Muskat M, Naoum FA, Noronha SA, Ouederni M, Ozono S, Richmond GW, Sakovich I, Salzer U, Schuetz C, Seeborg FO, Sharapova SO, Sockel K, Volokha A, von Bonin M, Warnatz K, Wegehaupt O, Weinberg GA, Wong KJ, Worth A, Yu H, Zharankova Y, Zhao X, Devlin L, Badarau A, Csomos K, Keszei M, Pereira J, Taveras AG, Beaussant-Cohen SL, Ong MS, Shcherbina A, Walter JE. PMID: 35947323; PMCID: PMC9700649.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    22. Mepolizumab prefilled syringe for the treatment of severe eosinophilic asthma: focus on the pediatric population. Expert Rev Respir Med. 2022 08; 16(8):857-865. Revier MD, Geng B. PMID: 35916083.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Balancing B cell responses to the allograft: implications for vaccination. Front Immunol. 2022; 13:948379. Crane C, Loop L, Anterasian C, Geng B, Ingulli E. PMID: 35967363; PMCID: PMC9363634.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    24. Atopic dermatitisReview of comorbidities and therapeutics. Ann Allergy Asthma Immunol. 2022 08; 129(2):142-149. Appiah MM, Haft MA, Kleinman E, Laborada J, Lee S, Loop L, Geng B, Eichenfield LF. PMID: 35609746.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. 2022 07; 163(1):59-76. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. PMID: 35606197; PMCID: PMC9233087.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    26. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. J Allergy Clin Immunol. 2022 07; 150(1):33-47. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. PMID: 35606166; PMCID: PMC9549868.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. The impact of maternal asthma on the preterm infants' gut metabolome and microbiome (MAP study). Sci Rep. 2022 04 19; 12(1):6437. Bai-Tong SS, Thoemmes MS, Weldon KC, Motazavi D, Kitsen J, Hansen S, Furst A, Geng B, Song SJ, Gilbert JA, Bode L, Dorrestein PC, Knight R, Leibel SA, Leibel SL. PMID: 35440708; PMCID: PMC9018729.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Activated phosphoinositide 3-kinase δ syndrome associated with nephromegaly, growth hormone deficiency, bronchiectasis: a case report. Allergy Asthma Clin Immunol. 2022 Feb 21; 18(1):15. Craig M, Geng B, Wigby K, Wigby K, Phillips SA, Bakhoum C, Naheedy J, Cernelc-Kohan M. PMID: 35189965; PMCID: PMC8862239.
      View in: PubMed   Mentions: 4  
    29. Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol. 2022 05; 128(5):553-560. Geng B, Dixon AE, Ko J, Janampally P, Haselkorn T, Holweg CTJ, Casale TB, Jarjour N. PMID: 35101644.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    30. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies. J Allergy Clin Immunol Pract. 2022 03; 10(3):732-741. Geng B, Bachert C, Busse WW, Gevaert P, Lee SE, Niederman MS, Chen Z, Lu X, Khokhar FA, Kapoor U, Pandit-Abid N, Jacob-Nara JA, Rowe PJ, Deniz Y, Ortiz B. PMID: 34954123.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole. Clin Rev Allergy Immunol. 2022 Jun; 62(3):463-475. Dilley M, Geng B. PMID: 34910281; PMCID: PMC9156451.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedema. Ann Allergy Asthma Immunol. 2022 03; 128(3):263-268. Geng B, Craig TJ. PMID: 34673223.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    33. Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis. Dermatol Ther (Heidelb). 2021 Oct; 11(5):1679. Geng B, Hebert AA, Takiya L, Miller L, Werth JL, Zang C, Sanders P, Lebwohl MG. PMID: 34550541; PMCID: PMC8484402.
      View in: PubMed   Mentions:
    34. Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis. Dermatol Ther (Heidelb). 2021 Oct; 11(5):1667-1678. Geng B, Hebert AA, Takiya L, Miller L, Werth JL, Zang C, Sanders P, Lebwohl MG. PMID: 34379285; PMCID: PMC8484488.
      View in: PubMed   Mentions: 3  
    35. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis. Curr Allergy Asthma Rep. 2021 06 10; 21(6):36. Geng B, Dilley M, Anterasian C. PMID: 34110505.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    36. Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]). Immunotherapy. 2021 07; 13(10):813-824. Kobayashi RH, Mandujano JF, Rehman SM, Kobayashi AL, Geng B, Atkinson TP, Melamed I, Turpel-Kantor E, Clodi E, Gupta S. PMID: 33955240.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    37. Primary immunodeficiency diseases treated with immunoglobulin and associated comorbidities. Allergy Asthma Proc. 2021 01 01; 42(1):78-86. Dilley M, Wangberg H, Noone J, Geng B. PMID: 33404391; PMCID: PMC7768070.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021 01; 100:106228. Phipatanakul W, Mauger DT, Guilbert TW, Bacharier LB, Durrani S, Jackson DJ, Martinez FD, Fitzpatrick AM, Cunningham A, Kunselman S, Wheatley LM, Bauer C, Davis CM, Geng B, Kloepfer KM, Lapin C, Liu AH, Pongracic JA, Teach SJ, Chmiel J, Gaffin JM, Greenhawt M, Gupta MR, Lai PS, Lemanske RF, Morgan WJ, Sheehan WJ, Stokes J, Thorne PS, Oettgen HC, Israel E, PARK Study Team. PMID: 33242697; PMCID: PMC7887056.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    39. Correlation of skin prick testing to environmental allergens. Ann Allergy Asthma Immunol. 2021 04; 126(4):378-384.e2. Grobman L, Kitsen J, Mortazavi D, Geng B. PMID: 33122125.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    40. Screening Social Determinants of Health in a Multidisciplinary Severe Asthma Clinical Program. Pediatr Qual Saf. 2020 Sep-Oct; 5(5):e360. Leibel S, Geng B, Phipatanakul W, Lee E, Hartigan P. PMID: 33204931; PMCID: PMC7665245.
      View in: PubMed   Mentions: 13  
    41. Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3643-3646.e1. Galant-Swafford J, Geng B, Leibel S, Akuthota P, Tucker S, Cernelc-Kohan M, Sheets R, Nation J, Jefferson AA. PMID: 32668296.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG. J Clin Immunol. 2019 11; 39(8):814-822. Anterasian C, Duong R, Gruenemeier P, Ernst C, Kitsen J, Geng B. PMID: 31673923; PMCID: PMC6863943.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    43. Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype. J Allergy Clin Immunol. 2019 11; 144(5):1336-1342.e7. Gupta A, Ikeda M, Geng B, Azmi J, Price RG, Bradford ES, Yancey SW, Steinfeld J. PMID: 31425781.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsCTClinical Trials
    44. Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol. 2019 07; 123(1):70-80. Gerstlauer M, Szepfalusi Z, Golden D, Geng B, de Blic J. PMID: 31009701.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCTClinical Trials
    45. Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies. Front Immunol. 2019; 10:40. Kobayashi RH, Gupta S, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Turpel-Kantor E, Litzman J. PMID: 30778345; PMCID: PMC6369354.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    46. Penicillin skin testing in the management of penicillin allergy in an outpatient pediatric population. Allergy Asthma Proc. 2018 Jul 01; 39(4):305-310. Anterasian CM, Geng B. PMID: 30095396; PMCID: PMC9292462.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    47. Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma. J Asthma. 2019 03; 56(3):263-269. Han J, Nguyen J, Kim Y, Geng B, Romanowski G, Alejandro L, Proudfoot J, Xu R, Leibel S. PMID: 29672188.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    48. Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease. Respir Med. 2017 Nov; 132:181-188. Berger M, Geng B, Cameron DW, Murphy LM, Schulman ES. PMID: 29229095.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    49. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann Allergy Asthma Immunol. 2017 09; 119(3):258-261. Geng B, Eastman JJ, Mori K, Braskett M, Riedl MA. PMID: 28743423.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Lichenoid Dermatitis in an Adult with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome. Skinmed. 2017; 15(3):231-234. Choi YM, Wang YT, Geng B, Garcia-Lloret M, Smart CN. PMID: 28705291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Recalcitrant Verrucae in Patients With DOCK8 Deficiency. Skinmed. 2016; 14(4):315-317. Wang YT, Geng B, Gendelman S, Freeman A, Kim CN. PMID: 27784527.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):33-8. Geng B, Thakor A, Clayton E, Finkas L, Riedl MA. PMID: 25959032.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Successful stem cell transplantation in Chediak-Higashi syndrome. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):271-2. Thakor A, Geng B, Liebhaber M, Moore T, Wang K, Roberts RL. PMID: 25609327.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Cutaneous granulomas and epidermodysplasia verruciformis in early onset combined immunodeficiency syndrome. Am J Dermatopathol. 2014 Feb; 36(2):179-83. Wang YT, Geng B, Yoo KY, Stiehm ER, Garcia-Lloret M, Wong D, Smart C, Worswick S, Barnhill RL. PMID: 24247584.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013 Jan-Feb; 34(1):13-8. Geng B, Riedl MA. PMID: 23406930.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Bob's Networks
    Concepts (227)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (51)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California